The safety and efficacy of antithyroid drugs.

作者: Fereidoun Azizi

DOI: 10.1517/14740338.5.1.107

关键词:

摘要: Thionamides, selective inhibitors of thyroid peroxidase-mediated iodination by tyrosine residues in thyroglobulin, have been effectively used the treatment hyperthyroidism. The choices for initial patients with Graves' disease differ various countries, and many physicians around world prefer to administer thionamide drugs as first choice Although some thyroidologists more often consider radioiodine be because its safety ease administration, thionamides remain mainstay thyrotoxic children adolescents hyperthyroid women during pregnancy, postpartum period lactation. A recent study continuous shows efficacy, cost-benefit properties. Further studies effectiveness therapy thyrotoxicosis need designed implemented determine indications such children, adults diffuse toxic goiter, particular, those who had recurrence hyperthyroidism after discontinuation one complete course treatment.

参考文章(111)
R. Jansson, B. Lindström, P. A. Dahlberg, Pharmacokinetic properties and bioavailability of methimazole Clinical Pharmacokinectics. ,vol. 10, pp. 443- 450 ,(1985) , 10.2165/00003088-198510050-00006
Stefan K. G. Grebe, Colin M. Feek, Henry C. Ford, Jocelyn N. Fagerström, Diane P. Cordwell, John W. Delahunt, Robyn J. Toomath, A randomized trial of short‐term treatment of Graves' disease with high‐dose carbimazole plus thyroxine versus low‐dose carbimazole Clinical Endocrinology. ,vol. 48, pp. 585- 592 ,(1998) , 10.1046/J.1365-2265.1998.00446.X
D M Arab, D A Malatjalian, R S Rittmaster, Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. The Journal of Clinical Endocrinology & Metabolism. ,vol. 80, pp. 1083- 1085 ,(1995) , 10.1210/JCEM.80.4.7714072
B Biondi, S Fazio, C Carella, G Amato, A Cittadini, G Lupoli, L Saccà, A Bellastella, G Lombardi, Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine* The Journal of Clinical Endocrinology and Metabolism. ,vol. 77, pp. 334- 338 ,(1993) , 10.1210/JCEM.77.2.8345037
F Azizi, L Ataie, M Hedayati, Y Mehrabi, F Sheikholeslami, Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine European Journal of Endocrinology. ,vol. 152, pp. 695- 701 ,(2005) , 10.1530/EJE.1.01904
G. KALLNER, S. VITOLS, J. G. LJUNGGREN, Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. Journal of Internal Medicine. ,vol. 239, pp. 525- 529 ,(1996) , 10.1046/J.1365-2796.1996.489827000.X
Jens Faber, Anders Michael Galløe, Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis European Journal of Endocrinology. ,vol. 130, pp. 350- 356 ,(1994) , 10.1530/EJE.0.1300350
Jorge K Ruiz, Giorgio V Rossi, Humberto A Vallejos, Rosemarie W Brenet, Isabel B Lopez, Alfonso A Escribano, Fulminant Hepatic Failure Associated with Propylthiouracil Annals of Pharmacotherapy. ,vol. 37, pp. 224- 228 ,(2003) , 10.1177/106002800303700213
Prakash Abraham, Alison Avenell, Susan C McGeoch, Louise F Clark, John S Bevan, Antithyroid drug regimen for treating Graves' hyperthyroidism Cochrane Database of Systematic Reviews. ,vol. 2010, ,(2010) , 10.1002/14651858.CD003420.PUB4